A handful of British Columbians are helping test a new “gene silencing” drug designed to halt production of a toxic protein that causes brain wasting in Huntington Disease.
October 21st, 2015 A handful of British Columbians are helping test a new “gene silencing” drug designed to halt production of a toxic protein that causes brain wasting in Huntington Disease. A clinical trial now underway to prove the safety of the experimental drug ISIS-HTT will include 36 patients with very early symptoms of the […]